单唾液酸四己糖神经节苷脂钠联合鼠神经生长因子治疗Bell面瘫的回顾性研究
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

基金项目:

国家自然科学基金(81301313);江苏省自然科学基金(BK20131015);南京市医学科技发展专项资金(YKK13174)


GM1 combined with NGF for the treatment of Bell’s palsy: a retrospective study
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:探讨单唾液酸四己糖神经节苷脂钠(monosialotetrahexosylganglioside,GM1)联合鼠神经生长因子(nerve growth factor,NGF)在早期治疗Bell面瘫的临床疗效和短期预后。方法:回顾比较分析2009年1月—2015年9月219例Bell面瘫病例,其中GM1联合NGF组58例,GM1组55例,NGF组51例,未用特殊营养神经药物的基础组55例。所有病例基础治疗相同。通过比较治疗前及治疗后1、2、4周House-Brackmann分级、SunnyBrook综合评分,评价面神经功能的恢复程度。结果:GM1联合NGF组在治疗后2、4周的House-Brackmann分级及SunnyBrook评分均明显优于其他组,差异有统计学意义(P<0.01)。GM1联合NGF组在治疗后4周的痊愈率(91.4%)明显高于GM1组(74.5%)、NGF组(78.4%)及基础组(50.9%),差异有统计学意义(P<0.01)。结论:GM1联合NGF早期治疗Bell面瘫,在面神经功能的早期恢复和改善短期预后方面具有优势。

    Abstract:

    Objective: To evaluate the efficacy of treatment with monosialotetrahexosyl ganglioside(GM1) combined with mouse nerve growth factor(NGF) on early stage of treatment and short-term prognosis of acute Bell’s palsy. Methods: A retrospective study was conducted to analyze clinical data of 219 patients with Bell’s palsy from January 2009 to December 2015. The patients with acute Bell’s palsy were divided into four groups, including the GM1 combined with NGF group(58 cases), the GM1 group(55 cases), the NGF group(51 cases), and the basic group(without any special neurotrophic drugs, 55 cases). All cases had the same basic treatment. We used the House-Brackmann facial nerve grading system(HB) and the Sunnybrook grading system to evaluate the efficacy of treatment before starting treatment, after 1 week and 2 weeks of treatment and 1 month after onset. Results: There was greater improvement in the mean HB and Sunnybrook scores of the GM1 combined with NGF group in comparison to the other three groups at 2 weeks and 4 weeks(P<0.01). After 4 weeks, 91.4% patients had good recovery in the GM1 combined with NGF group compared with the other three groups(P<0.01), the recovery rates of the GM1 group, NGF group and basic group at the same time point were 74.5%, 78.4% and 50.9%, respectively. Conclusion: The combination of GM1 and NGF treatment increases the possibility of recovery in acute Bell’s palsy.

    参考文献
    相似文献
    引证文献
引用本文

陆倩羚,戴昕妤,葛瑶琪,戴 瑛,孙高慧,陈玉山,高志强,李云涛,张 鹏.单唾液酸四己糖神经节苷脂钠联合鼠神经生长因子治疗Bell面瘫的回顾性研究[J].南京医科大学学报(自然科学版),2017,(11):1437-1440,1454

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:2016-11-16
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2017-12-06
  • 出版日期: